US5320960A
(en)
*
|
1992-04-03 |
1994-06-14 |
Genencor International, Inc. |
Method of preparing solution enriched in xylanase using low molecular weight alcohol, organic salt and inorganic salt
|
US5298405A
(en)
*
|
1986-04-30 |
1994-03-29 |
Alko Limited |
Enzyme preparations with recombinantly-altered cellulose profiles and methods for their production
|
US5780292A
(en)
*
|
1987-04-29 |
1998-07-14 |
Alko Group Ltd. |
Production of phytate degrading enzymes in trichoderma
|
US5610034A
(en)
*
|
1987-04-29 |
1997-03-11 |
Alko Group Ltd. |
Immunoglobulin production by trichoderma
|
US5258287A
(en)
*
|
1988-03-22 |
1993-11-02 |
Genentech, Inc. |
DNA encoding and methods of production of insulin-like growth factor binding protein BP53
|
EP0406314B1
(en)
*
|
1988-03-24 |
1993-12-01 |
Novo Nordisk A/S |
A cellulase preparation
|
CA1333777C
(en)
|
1988-07-01 |
1995-01-03 |
Randy M. Berka |
Aspartic proteinase deficient filamentous fungi
|
CA1341226C
(en)
*
|
1988-08-16 |
2001-05-01 |
Wim Van Hartingsveldt |
Gene replacement as a tool for the construction of aspergillus strains
|
FR2649120B1
(fr)
*
|
1989-06-30 |
1994-01-28 |
Cayla |
Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
|
US5688290A
(en)
*
|
1989-10-19 |
1997-11-18 |
Genencor International, Inc. |
Degradation resistant detergent compositions based on cellulase enzymes
|
US5120463A
(en)
*
|
1989-10-19 |
1992-06-09 |
Genencor International, Inc. |
Degradation resistant detergent compositions based on cellulase enzymes
|
US5837515A
(en)
*
|
1990-05-16 |
1998-11-17 |
Alko-Yhtiot Oy |
Enzyme preparations and methods for their production
|
FI903443A
(fi)
*
|
1990-07-06 |
1992-01-07 |
Valtion Teknillinen |
Framstaellning av lackas genom rekombinantorganismer.
|
EP0539395A1
(en)
*
|
1990-07-16 |
1993-05-05 |
Alko Group Ltd. |
IMMUNOGLOBULIN PRODUCTION BY $i(TRICHODERMA)
|
US5650322A
(en)
*
|
1990-10-05 |
1997-07-22 |
Genencor International, Inc. |
Methods for stonewashing fabrics using endoglucanases
|
US5290474A
(en)
*
|
1990-10-05 |
1994-03-01 |
Genencor International, Inc. |
Detergent composition for treating cotton-containing fabrics containing a surfactant and a cellulase composition containing endolucanase III from trichoderma ssp
|
US5525507A
(en)
*
|
1990-10-05 |
1996-06-11 |
Genencor International, Inc. |
Methods for treating cotton-containing fabric with cellulase composition containing endoglucanase component and which is free of all CBH I component
|
US5654193A
(en)
*
|
1990-10-05 |
1997-08-05 |
Genencor International, Inc. |
Methods for treating cotton containing fabrics with cellulase
|
US5246853A
(en)
*
|
1990-10-05 |
1993-09-21 |
Genencor International, Inc. |
Method for treating cotton-containing fabric with a cellulase composition containing endoglucanase components and which composition is free of exo-cellobiohydrolase I
|
CA2093422C
(en)
*
|
1990-10-05 |
2001-04-03 |
|
DETERGENT COMPOSITIONS CONTAINING LOW CBH I CONTENT CELLULASE COMPOSITIONS
|
US5328841A
(en)
*
|
1990-10-05 |
1994-07-12 |
Genencor International, Inc. |
Methods for isolating EG III cellulase component and EG III cellulase in polyethylene glycol using inorganic salt and polyethylene glycol
|
DE69133612D1
(de)
*
|
1990-12-10 |
2009-04-02 |
Genencor Int |
Verbesserte Saccharifizierung von Zellulose durch Klonierung und Vervielfältigung des beta-Glukosidase Genes aus Trichoderma
|
DK0575462T3
(da)
*
|
1991-03-22 |
1995-11-06 |
Gist Brocades Bv |
Fremgangsmåde til fremstilling af chymosin
|
AU678356B2
(en)
*
|
1992-05-01 |
1997-05-29 |
Genencor International, Inc. |
Methods for treating cotton-containing fabrics with CBH I enriched cellulase
|
WO1994003072A1
(en)
*
|
1992-07-31 |
1994-02-17 |
Panlabs Incorporated |
Recombinant cells, dna constructs, vectors and methods for expressing phytate degrading enzymes in desired ratios
|
US5665585A
(en)
*
|
1992-09-03 |
1997-09-09 |
Alko-Yhiot Oy |
Recombinant production of glucoamylase P in trichoderma
|
GB9400623D0
(en)
*
|
1994-01-14 |
1994-03-09 |
Univ Leeds |
Exploitation of the cellulase enzyme complex of neurospora
|
US5877016A
(en)
|
1994-03-18 |
1999-03-02 |
Genentech, Inc. |
Human trk receptors and neurotrophic factor inhibitors
|
US5708142A
(en)
|
1994-05-27 |
1998-01-13 |
Genentech, Inc. |
Tumor necrosis factor receptor-associated factors
|
US7816129B2
(en)
|
1994-07-29 |
2010-10-19 |
Ab Enzymes Gmbh |
Production and secretion of proteins of bacterial origin in filamentous fungi
|
US5834251A
(en)
*
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
US5700686A
(en)
*
|
1995-06-06 |
1997-12-23 |
Iogen Corporation |
Protease-treated and purified cellulase compositions and methods for reducing backstaining during enzymatic stonewashing
|
ES2202469T5
(es)
|
1995-09-08 |
2011-06-06 |
Genentech, Inc. |
Proteína relacionada con el vegf.
|
EP1619250B1
(en)
|
1996-01-08 |
2009-11-25 |
Genentech, Inc. |
OB receptor variant and ligands
|
US5851984A
(en)
*
|
1996-08-16 |
1998-12-22 |
Genentech, Inc. |
Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
|
US6159462A
(en)
*
|
1996-08-16 |
2000-12-12 |
Genentech, Inc. |
Uses of Wnt polypeptides
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US6100076A
(en)
|
1997-01-31 |
2000-08-08 |
Genentech, Inc. |
O-fucosyltransferase
|
AU729158B2
(en)
|
1997-01-31 |
2001-01-25 |
Genentech Inc. |
O-fucosyltransferase
|
CA2286330C
(en)
|
1997-04-07 |
2008-06-10 |
Genentech, Inc. |
Anti-vegf antibodies
|
EP3260468A1
(en)
|
1997-04-07 |
2017-12-27 |
Genentech, Inc. |
Anti-vegf antibodies
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
DE69842224D1
(de)
|
1997-08-27 |
2011-05-26 |
Childrens Hosp Medical Center |
Molekular-mimetika von meningokokkalen B Epitopen
|
US6387657B1
(en)
|
1997-10-29 |
2002-05-14 |
Genentech, Inc. |
WISP polypeptides and nucleic acids encoding same
|
IL135607A0
(en)
|
1997-10-29 |
2001-05-20 |
Genentech Inc |
Wnt-1 inducible genes
|
NZ525914A
(en)
|
1998-03-10 |
2004-03-26 |
Genentech Inc |
Novel polypeptides and nucleic acids encoding the same
|
PT1076703E
(pt)
|
1998-05-15 |
2007-10-10 |
Genentech Inc |
''utilizações terapêuticas de polipéptido homólogos de il-17''
|
EP3112468A1
(en)
|
1998-05-15 |
2017-01-04 |
Genentech, Inc. |
Il-17 homologous polypeptides and therapeutic uses thereof
|
EP1865061A3
(en)
|
1998-05-15 |
2007-12-19 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
US20020172678A1
(en)
|
2000-06-23 |
2002-11-21 |
Napoleone Ferrara |
EG-VEGF nucleic acids and polypeptides and methods of use
|
JP2002527066A
(ja)
|
1998-10-15 |
2002-08-27 |
カイロン コーポレイション |
転移性乳癌および結腸癌調節遺伝子
|
EP1950300A3
(en)
|
1998-11-18 |
2011-03-23 |
Genentech, Inc. |
Antibody variants with higher binding affinity compared to parent antibodies
|
ATE408695T1
(de)
|
1998-12-16 |
2008-10-15 |
Novartis Vaccines & Diagnostic |
Menschliche cyclin-abhängige kinase (hpnqalre)
|
EP1820859B9
(en)
|
1998-12-22 |
2009-10-28 |
Genentech, Inc. |
Methods and compositions for inhibiting neoplastic cell growth
|
EP2386574A3
(en)
|
1999-01-15 |
2012-06-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
DE60043367D1
(de)
|
1999-06-15 |
2009-12-31 |
Genentech Inc |
Sekretierte und Transmembran-Polypeptide sowie Nukleinsäuren zu deren Kodierung
|
EP1189641B1
(en)
|
1999-06-25 |
2009-07-29 |
Genentech, Inc. |
HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES
|
AU783767B2
(en)
|
1999-10-14 |
2005-12-01 |
Takara Bio Usa, Inc. |
Anthozoa derived chromophores/fluorophores and methods for using the same
|
CA2491610A1
(en)
|
1999-12-01 |
2001-06-07 |
Kevin P. Baker |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
EP1897944B1
(en)
|
1999-12-23 |
2011-08-10 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
JP5250168B2
(ja)
|
2000-01-10 |
2013-07-31 |
ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド |
乳癌において差次的に発現される遺伝子
|
JP2003531588A
(ja)
|
2000-04-11 |
2003-10-28 |
ジェネンテック・インコーポレーテッド |
多価抗体とその用途
|
CA2648048A1
(en)
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
EP2275549A1
(en)
|
2000-06-23 |
2011-01-19 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
|
EP2287296A1
(en)
|
2000-06-26 |
2011-02-23 |
Novozymes A/S |
Lipolytic enzyme
|
EP2014303A2
(en)
|
2000-07-27 |
2009-01-14 |
Genentech, Inc. |
APO-2L receptor agonist and CPT-11 synergism
|
ATE412009T1
(de)
|
2000-08-24 |
2008-11-15 |
Genentech Inc |
Methode zur inhibierung von il-22 induziertem pap1
|
EP1944317A3
(en)
|
2000-09-01 |
2008-09-17 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7456001B2
(en)
|
2000-09-05 |
2008-11-25 |
Novozymes A/S |
Lipoxygenase
|
US6673580B2
(en)
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
FI120310B
(fi)
|
2001-02-13 |
2009-09-15 |
Valtion Teknillinen |
Parannettu menetelmä erittyvien proteiinien tuottamiseksi sienissä
|
KR20030085041A
(ko)
|
2001-03-22 |
2003-11-01 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
응고 인자 ⅶ 유도체
|
AU2002258728A1
(en)
|
2001-04-06 |
2002-10-21 |
Georgetown University |
Gene brcc-3 and diagnostic and therapeutic uses thereof
|
WO2002081639A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene brcc2 and diagnostic and therapeutic uses thereof
|
WO2002081641A2
(en)
|
2001-04-06 |
2002-10-17 |
Georgetown University |
Gene scc-112 and diagnostic and therapeutic uses thereof
|
CN100359006C
(zh)
|
2001-04-20 |
2008-01-02 |
诺和酶股份有限公司 |
脂肪氧合酶
|
US20070160576A1
(en)
|
2001-06-05 |
2007-07-12 |
Genentech, Inc. |
IL-17A/F heterologous polypeptides and therapeutic uses thereof
|
CA2633595A1
(en)
|
2001-06-20 |
2003-01-03 |
Genentech, Inc. |
Antibodies against tumor-associated antigenic target (tat) polypeptides
|
EP2311960A3
(en)
|
2001-08-29 |
2011-06-01 |
Genentech, Inc. |
Bv8 nucleic acids and polypeptides with mitogenic activity
|
ATE486092T1
(de)
|
2001-09-18 |
2010-11-15 |
Genentech Inc |
Zusammensetzungen und verfahren für die diagnose von tumoren
|
HUP0500060A3
(en)
|
2001-09-27 |
2010-01-28 |
Novo Nordisk Healthcare Ag |
Human coagulation factor vii polypeptides
|
PT2279755E
(pt)
|
2001-10-10 |
2014-06-04 |
Ratiopharm Gmbh |
Remodelação e glicoconjugação do factor de crescimento de fibroblastos (fgf)
|
DK2279753T3
(en)
|
2001-10-10 |
2015-11-23 |
Novo Nordisk As |
The conversion of peptides and glycokonjugering
|
EP1456223B1
(en)
|
2001-12-19 |
2009-08-12 |
The University Of Chicago |
Rapidly maturing fluorescent proteins and methods for using the same
|
EP2067472A1
(en)
|
2002-01-02 |
2009-06-10 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
CA2476518A1
(en)
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
US7138512B2
(en)
|
2002-04-10 |
2006-11-21 |
Georgetown University |
Gene SHINC-2 and diagnostic and therapeutic uses thereof
|
US7244565B2
(en)
|
2002-04-10 |
2007-07-17 |
Georgetown University |
Gene shinc-3 and diagnostic and therapeutic uses thereof
|
CA2481507A1
(en)
|
2002-04-16 |
2003-10-30 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
EP2305710A3
(en)
|
2002-06-03 |
2013-05-29 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
AU2003243400B2
(en)
|
2002-06-07 |
2009-10-29 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
CA2490758C
(en)
|
2002-07-15 |
2014-09-23 |
Genentech, Inc. |
Dosage form of recombinant humanized monoclonal antibody 2c4
|
EP2277532A1
(en)
|
2002-09-11 |
2011-01-26 |
Genentech, Inc. |
Novel composition and methods for the treatment of immune related diseases
|
EP2332996B1
(en)
|
2002-09-11 |
2014-10-15 |
Genentech, Inc. |
Purification of anti-Her2 antibodies
|
CA2497334A1
(en)
|
2002-09-11 |
2004-03-25 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
US20070010434A1
(en)
|
2002-09-16 |
2007-01-11 |
Genetech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
WO2004028479A2
(en)
|
2002-09-25 |
2004-04-08 |
Genentech, Inc. |
Nouvelles compositions et methodes de traitement du psoriasis
|
EP2322202A3
(en)
|
2002-10-29 |
2011-07-27 |
Genentech, Inc. |
Compositions and methods for the treatment of immune diseases
|
CA2503748A1
(en)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions and methods for the treatment of natural killer cell related diseases
|
EP2179742A1
(en)
|
2002-11-26 |
2010-04-28 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
PT1572744E
(pt)
|
2002-12-16 |
2010-09-07 |
Genentech Inc |
Variantes de imunoglobulina e utilizações destas
|
US7575893B2
(en)
|
2003-01-23 |
2009-08-18 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
US7632810B2
(en)
|
2003-03-12 |
2009-12-15 |
Genentech, Inc. |
Compositions with hematopoietic and immune activity
|
AU2004229335C1
(en)
|
2003-04-04 |
2010-06-17 |
Genentech, Inc. |
High concentration antibody and protein formulations
|
EP1615945B1
(en)
|
2003-04-09 |
2011-09-28 |
BioGeneriX AG |
Glycopegylation methods and proteins/peptides produced by the methods
|
NZ553115A
(en)
|
2003-04-28 |
2008-04-30 |
Novozymes As |
Method of producing a phospholipase which comprises processing an expressed fungal peptide so as to cleave off a peptide from the C- terminal end and/or a peptide from the N-terminal end to obtain a core peptide
|
CN101274098A
(zh)
|
2003-05-30 |
2008-10-01 |
健泰科生物技术公司 |
利用抗-vegf抗体的治疗
|
PL1641823T3
(pl)
|
2003-06-12 |
2012-02-29 |
Lilly Co Eli |
Białka fuzyjne analogu GLP-1
|
MX341074B
(es)
|
2003-07-08 |
2016-08-05 |
Genentech Inc |
Polipeptidos heterologos il-17 a/f y usos terapeuticos de los mismos.
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
EP2392655A3
(en)
|
2003-09-09 |
2012-02-29 |
Novo Nordisk Health Care AG |
Coagulation factor VII polypeptides
|
CA2546285C
(en)
|
2003-11-17 |
2015-12-29 |
Genentech, Inc. |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
BRPI0416762A
(pt)
|
2003-11-21 |
2007-02-27 |
Genencor Int |
expressão de enzimas hidrolisantes de amido granular em trinchoderma e processo para produzir glicose a partir de substratos de amido granular
|
WO2005068503A2
(en)
|
2004-01-07 |
2005-07-28 |
Chiron Corporation |
M-csf-specific monoclonal antibody and uses thereof
|
GB2429207A
(en)
|
2004-02-02 |
2007-02-21 |
Ambrx Inc |
Modified human interferon polypeptides and their uses
|
CN1930294A
(zh)
|
2004-03-25 |
2007-03-14 |
金克克国际有限公司 |
纤维素酶融合蛋白和编码该纤维素酶融合蛋白的异源纤维素酶融合构建物
|
US8097445B2
(en)
|
2004-03-25 |
2012-01-17 |
Danisco Us Inc. |
Exo-endo cellulase fusion protein
|
KR101222281B1
(ko)
|
2004-03-29 |
2013-01-28 |
가르파마 컴퍼니 리미티드 |
신규 갈렉틴 9 개변체 단백질 및 그 용도
|
RU2429245C2
(ru)
|
2004-03-30 |
2011-09-20 |
Глаксо Груп Лимитед |
Иммуноглобулины
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
EP1732944B1
(en)
|
2004-04-07 |
2012-09-05 |
The University of Chicago |
Monomeric red fluorescent proteins
|
US20150017671A1
(en)
|
2004-04-16 |
2015-01-15 |
Yaping Shou |
Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
|
US7413887B2
(en)
|
2004-05-27 |
2008-08-19 |
Genecor International, Inc. |
Trichoderma reesei glucoamylase and homologs thereof
|
CN1981037B
(zh)
|
2004-05-27 |
2011-08-31 |
金克克国际有限公司 |
白曲霉酸稳定性α淀粉酶的异源表达和在颗粒淀粉水解中的应用
|
US7332319B2
(en)
|
2004-05-27 |
2008-02-19 |
Genencor International, Inc. |
Heterologous alpha amylase expression in Aspergillus
|
CA2567570C
(en)
|
2004-05-27 |
2014-07-08 |
Genencor International, Inc. |
Aspergillus kawachi acid-stable alpha amylase and applications in granular starch hydrolysis
|
JP2008503217A
(ja)
|
2004-06-18 |
2008-02-07 |
アンブレツクス・インコーポレイテツド |
新規抗原結合ポリペプチド及びそれらの使用
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
CN102641503A
(zh)
|
2004-07-20 |
2012-08-22 |
健泰科生物技术公司 |
血管生成素样4蛋白抑制剂,组合,以及其用途
|
FI118339B
(fi)
|
2004-09-21 |
2007-10-15 |
Ab Enzymes Oy |
Uusi lakkaasientsyymi ja sen käyttö
|
WO2006053110A2
(en)
|
2004-11-10 |
2006-05-18 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
BRPI0519430A2
(pt)
|
2004-12-22 |
2009-02-10 |
Ambrx Inc |
hormânio do crescimento humano modificado
|
SG158149A1
(en)
|
2004-12-22 |
2010-01-29 |
Ambrx Inc |
Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
|
EP1841793B1
(en)
|
2005-01-07 |
2010-03-31 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
CA2597980C
(en)
|
2005-02-18 |
2016-01-05 |
Genencor International, Inc. |
Polypeptides having alpha-amylase and granular starch hydrolyzing activity
|
CA2602175C
(en)
|
2005-03-21 |
2012-11-27 |
Applera Corporation |
Alpha ketoamide compounds as cysteine protease inhibitors
|
EP2333045B1
(en)
|
2005-04-12 |
2016-11-09 |
Danisco US Inc. |
Gene inactivated mutants with altered protein production
|
US7741093B2
(en)
|
2005-04-29 |
2010-06-22 |
Ab Enzymes Oy |
Cellulases and their uses
|
ES2609429T3
(es)
|
2005-05-12 |
2017-04-20 |
Zymogenetics, Inc. |
Composiciones y métodos para modular respuestas inmunitarias
|
WO2006132788A2
(en)
|
2005-06-06 |
2006-12-14 |
Genentech, Inc. |
Transgenic models for different genes and their use for gene characterization
|
AU2006280321A1
(en)
|
2005-08-15 |
2007-02-22 |
Genentech, Inc. |
Gene disruptions, compositions and methods relating thereto
|
WO2007031559A2
(en)
|
2005-09-14 |
2007-03-22 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
WO2007053732A2
(en)
|
2005-11-01 |
2007-05-10 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the blys gene and use in diagnostic methods
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
WO2007059312A2
(en)
|
2005-11-16 |
2007-05-24 |
Ambrx, Inc. |
Methods and compositions comprising non-natural amino acids
|
MY147669A
(en)
|
2005-11-18 |
2012-12-31 |
Glenmark Pharmaceuticals Sa |
Anti-alpha2 integrin antibodies and their uses
|
ZA200804162B
(en)
|
2005-11-21 |
2009-12-30 |
Genentech Inc |
Novel gene disruptions, compositions and methods relating thereto
|
GB0525662D0
(en)
|
2005-12-16 |
2006-01-25 |
Glaxo Group Ltd |
Immunoglobulins
|
US7256032B2
(en)
|
2005-12-22 |
2007-08-14 |
Ab Enzymes Oy |
Enzymes
|
DK1969123T3
(en)
|
2005-12-22 |
2017-08-28 |
Ab Enzymes Oy |
Hitherto UNKNOWN ENZYMS
|
WO2007114979A2
(en)
|
2006-02-17 |
2007-10-11 |
Genentech, Inc. |
Gene disruptons, compositions and methods relating thereto
|
JP2009531031A
(ja)
|
2006-03-23 |
2009-09-03 |
ノバルティス アーゲー |
抗−腫瘍細胞抗原抗体療法
|
RU2466740C2
(ru)
|
2006-04-05 |
2012-11-20 |
Эбботт Байотекнолоджи Лтд. |
Очистка антитела
|
AU2007243946B2
(en)
|
2006-04-05 |
2012-11-29 |
Curis, Inc. |
Method for using BOC/CDO to modulate hedgehog signaling
|
US7361487B2
(en)
|
2006-04-13 |
2008-04-22 |
Ab Enzymes Oy |
Enzyme fusion proteins and their use
|
AU2007297565A1
(en)
|
2006-04-19 |
2008-03-27 |
Genentech, Inc. |
Novel gene disruptions, compositions and methods relating thereto
|
EP3026123A1
(en)
|
2006-04-27 |
2016-06-01 |
Klaritos, Inc. |
Method and kit for predicting antibody therapy
|
AU2007249160B2
(en)
|
2006-05-15 |
2013-09-12 |
I2 Pharmaceuticals, Inc. |
Neutralizing antibodies to influenza viruses
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
ES2523640T3
(es)
|
2006-06-21 |
2014-11-28 |
Musc Foundation For Research Development |
Direccionamiento del factor H del complemento para el tratamiento de enfermedades
|
CN101484471B
(zh)
|
2006-06-30 |
2013-11-06 |
诺沃-诺迪斯克有限公司 |
抗-nkg2a抗体及其用途
|
US20080026376A1
(en)
|
2006-07-11 |
2008-01-31 |
Huaming Wang |
KEX2 cleavage regions of recombinant fusion proteins
|
AU2007285855B2
(en)
|
2006-08-18 |
2013-03-07 |
Novartis Ag |
PRLR-specific antibody and uses thereof
|
EP2615108B1
(en)
|
2006-09-08 |
2016-10-26 |
Ambrx, Inc. |
Modified human plasma polypeptide or fc scaffolds and thier uses
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
JP5568307B2
(ja)
|
2006-10-10 |
2014-08-06 |
ダニスコ・ユーエス・インク、ジェネンコー・ディビジョン |
修飾された性質を有するグルコアミラーゼ変異体
|
WO2009048487A1
(en)
|
2007-10-09 |
2009-04-16 |
Danisco Us, Inc., Genencor Division |
Glucoamylase variants
|
RU2460541C2
(ru)
|
2006-10-27 |
2012-09-10 |
Лпат, Инк. |
Композиции и способы связывания сфингозин-1-фосфата
|
WO2008055072A2
(en)
|
2006-10-27 |
2008-05-08 |
Lpath, Inc. |
Compositions and methods for treating ocular diseases and conditions
|
WO2008140477A2
(en)
|
2006-11-02 |
2008-11-20 |
Capon Daniel J |
Hybrid immunoglobulins with moving parts
|
US7943329B2
(en)
|
2006-11-14 |
2011-05-17 |
Genentech, Inc. |
Modulators of neuronal regeneration
|
MX2009005466A
(es)
|
2006-11-22 |
2009-08-17 |
Adnexus A Bristol Myers Sqibb |
Terapeuticos dirigidos a base de proteinas manipuladas para receptores de tirosina cinasas, incluyendo receptor de factor de crecimiento tipo insulina-i.
|
AU2007325283B2
(en)
|
2006-11-27 |
2012-08-30 |
Diadexus, Inc. |
Ovr110 antibody compositions and methods of use
|
CN101687032A
(zh)
|
2006-12-07 |
2010-03-31 |
诺瓦提斯公司 |
抗ephb3的拮抗剂抗体
|
US7947813B2
(en)
|
2007-01-22 |
2011-05-24 |
Genentech, Inc. |
Polyelectrolyte precipitation and purification of proteins
|
ATE516814T1
(de)
|
2007-02-02 |
2011-08-15 |
Bristol Myers Squibb Co |
10fn3 domain zur behandlung von krankheiten begleitet von unerwünschter angiogenese
|
US20080220498A1
(en)
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
US8143046B2
(en)
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
AU2008218199B2
(en)
|
2007-02-22 |
2013-10-31 |
Genentech, Inc. |
Methods for detecting inflammatory bowel disease
|
MX2009009658A
(es)
|
2007-03-14 |
2009-09-22 |
Danisco Us Inc Genencor Div |
Alfa-amilasa de trichoderma reesei que mejora la sacarificacion del almidon de maiz.
|
KR20160121601A
(ko)
|
2007-03-30 |
2016-10-19 |
암브룩스, 인코포레이티드 |
변형된 fgf-21 폴리펩티드 및 그 용도
|
EP2147104B1
(en)
|
2007-05-21 |
2015-09-09 |
Danisco US Inc. |
Use of an aspartic protease (nsp24) signal sequence for heterologous protein expression
|
US8158124B2
(en)
|
2007-05-30 |
2012-04-17 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
US9163091B2
(en)
|
2007-05-30 |
2015-10-20 |
Lpath, Inc. |
Compositions and methods for binding lysophosphatidic acid
|
WO2008154251A2
(en)
|
2007-06-07 |
2008-12-18 |
Genentech, Inc. |
C3b antibodies and methods for the prevention and treatment of complement- associated disorders
|
SI3597659T1
(sl)
|
2007-07-09 |
2023-04-28 |
Genentech, Inc. |
Preprečevanje redukcije disulfidne vezi med rekombinantno proizvodnjo polipeptidov
|
BRPI0813514A2
(pt)
|
2007-07-16 |
2019-09-24 |
Genentech Inc |
anticorpos anti-cd79b humanizados e imunoconjugados e métodos de uso
|
PT2474557E
(pt)
|
2007-07-16 |
2014-12-03 |
Genentech Inc |
Anticorpos e imunoconjugados anti-cd79b e métodos de utilização
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗脂肪肝中的应用
|
WO2009031992A1
(en)
*
|
2007-09-04 |
2009-03-12 |
Elizabeth Varriano-Marston |
Method for controlling banana quality by packaging
|
US8044192B2
(en)
|
2007-09-12 |
2011-10-25 |
Danisco Us Inc. |
Trichoderma promoter
|
CA2971794C
(en)
|
2007-10-04 |
2020-03-24 |
Zymogenetics, Inc. |
B7 family member zb7h6 and related compositions and methods
|
US8592194B2
(en)
|
2007-10-09 |
2013-11-26 |
Danisco Us Inc. |
Glucoamylase variants with altered properties
|
US8361465B2
(en)
|
2007-10-26 |
2013-01-29 |
Lpath, Inc. |
Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents
|
ES2666170T3
(es)
|
2007-10-30 |
2018-05-03 |
Genentech, Inc. |
Purificación de anticuerpos mediante cromatografía de intercambio catiónico
|
WO2009059305A2
(en)
|
2007-11-01 |
2009-05-07 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
WO2009061910A1
(en)
|
2007-11-08 |
2009-05-14 |
Genetech, Inc. |
Anti-factor b antibodies and their uses
|
MX2010005244A
(es)
|
2007-11-12 |
2010-10-25 |
Theraclone Sciences Inc |
Composiciones y métodos para la terapia y el diagnóstico de influenza.
|
EP3323889B1
(en)
|
2007-11-20 |
2020-03-25 |
Danisco US Inc. |
Glucoamylase variants with altered properties
|
US8946148B2
(en)
|
2007-11-20 |
2015-02-03 |
Ambrx, Inc. |
Modified insulin polypeptides and their uses
|
AR069501A1
(es)
|
2007-11-30 |
2010-01-27 |
Genentech Inc |
Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
|
US8003325B2
(en)
|
2007-11-30 |
2011-08-23 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the BLyS gene and use in diagnostic methods
|
AU2008334945C1
(en)
|
2007-12-13 |
2013-09-05 |
Danisco Us Inc. |
Compositions and methods for producing isoprene
|
CN101918545A
(zh)
|
2008-01-02 |
2010-12-15 |
丹尼斯科美国公司 |
应用嗜糖假单胞菌g4-淀粉酶和其变体获得乙醇的无葡糖淀粉酶的方法
|
AR070141A1
(es)
|
2008-01-23 |
2010-03-17 |
Glenmark Pharmaceuticals Sa |
Anticuerpos humanizados especificos para el factor von willebrand
|
RU2010133892A
(ru)
|
2008-01-24 |
2012-02-27 |
Ново Нордиск А/С (DK) |
Гуманизированные моноклональные антитела против человеческого nkg2a
|
SI2247620T1
(sl)
|
2008-01-31 |
2016-09-30 |
Genentech, Inc. |
Protitelesa proti CD79b in imunokonjugati in postopki za uporabo
|
NZ586947A
(en)
|
2008-02-08 |
2012-11-30 |
Ambrx Inc |
Modified leptin polypeptides and their uses
|
WO2009102755A1
(en)
|
2008-02-11 |
2009-08-20 |
Danisco Us Inc., Genencor Division |
Enzyme with microbial lysis activity from trichoderma reesei
|
EP2257571B1
(en)
|
2008-03-10 |
2015-03-04 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of cytomegalovirus infections
|
CN102046656A
(zh)
|
2008-03-28 |
2011-05-04 |
航道生物技术有限责任公司 |
针对病毒抗原的中和性分子
|
CA3179151A1
(en)
|
2008-04-09 |
2009-10-15 |
Genentech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
DK3118309T3
(da)
|
2008-04-18 |
2020-12-14 |
Danisco Us Inc |
Buttiauxella sp. phytasevarianter
|
WO2009132220A2
(en)
|
2008-04-23 |
2009-10-29 |
Danisco Us Inc. |
Isoprene synthase variants for improved microbial production of isoprene
|
ES2605471T3
(es)
|
2008-05-06 |
2017-03-14 |
Genentech, Inc. |
Variantes de CRIg de afinidad madurada
|
MY156256A
(en)
|
2008-07-02 |
2016-01-29 |
Danisco Us Inc |
Compositions and methods for producing isoprene free of c5 hydrocarbons under decoupling conditions and/or safe operating ranges
|
US10138283B2
(en)
|
2008-07-23 |
2018-11-27 |
Ambrx, Inc. |
Modified bovine G-CSF polypeptides and their uses
|
KR102196883B1
(ko)
|
2008-08-14 |
2020-12-30 |
제넨테크, 인크. |
고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법
|
CL2009001823A1
(es)
|
2008-09-05 |
2011-04-29 |
TransAlgae Ltd |
Metodo para mantener un monocultivo de cianobacterias o algas libres de especies no deseadas, que comprende transformar dichas cianobacterias o algas para expresar resistencia contra un herbicida, cultivar dichas cianobacterias o algas, proveer altas concentraciones de co2 y agegar herbicidas al medio de cultivo.
|
WO2010031068A1
(en)
|
2008-09-15 |
2010-03-18 |
Danisco Us Inc. |
Reduction of carbon dioxide emission during isoprene production by fermentation
|
EP2334788A1
(en)
|
2008-09-15 |
2011-06-22 |
Danisco US Inc. |
Increased isoprene production using the archaeal lower mevalonate pathway
|
EP2340312A2
(en)
|
2008-09-15 |
2011-07-06 |
Danisco US Inc. |
Conversion of prenyl derivatives to isoprene
|
WO2010031079A1
(en)
|
2008-09-15 |
2010-03-18 |
Danisco Us Inc. |
Systems using cell culture for production of isoprene
|
WO2010034015A2
(en)
|
2008-09-22 |
2010-03-25 |
The Regents Of The University Of Colorado, A Body Corporate |
Modulating the alternative complement pathway
|
NZ601659A
(en)
|
2008-09-26 |
2014-02-28 |
Ambrx Inc |
Modified animal erythropoietin polypeptides and their uses
|
EA201170493A1
(ru)
|
2008-09-26 |
2011-10-31 |
Амбркс, Инк. |
Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
|
TWI610936B
(zh)
|
2008-10-20 |
2018-01-11 |
艾伯維有限公司 |
使用蛋白質a親和性層析進行抗體之分離及純化
|
MX2011004306A
(es)
|
2008-10-22 |
2011-07-28 |
Genentech Inc |
Modulacion de degeneracion de axones.
|
US8871202B2
(en)
|
2008-10-24 |
2014-10-28 |
Lpath, Inc. |
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
|
CA2742899A1
(en)
|
2008-11-06 |
2010-05-14 |
Glenmark Pharmaceuticals, S.A. |
Treatment with anti-alpha2 integrin antibodies
|
CA2746118A1
(en)
|
2008-12-15 |
2010-07-01 |
Danisco Us Inc. |
Hybrid alpha-amylases
|
AR074777A1
(es)
|
2008-12-19 |
2011-02-09 |
Glaxo Group Ltd |
Proteinas de union a antigeno
|
FI20086236A0
(fi)
|
2008-12-23 |
2008-12-23 |
Valtion Teknillinen |
Heksuronihapon konversio heksarihapoksi
|
FI122029B
(fi)
|
2008-12-30 |
2011-07-29 |
Ab Enzymes Oy |
Sieniperäiset endoglukanaasit, niiden tuotto ja käyttö
|
CN102333866B
(zh)
|
2008-12-30 |
2015-04-29 |
丹尼斯科美国公司 |
生产异戊二烯和共同产物的方法
|
WO2010078376A2
(en)
|
2008-12-30 |
2010-07-08 |
Ventana Medical Systems, Inc. |
Fc-specific polymer-conjugated antibodies and their diagnostic use
|
EP3178835B1
(en)
|
2009-02-03 |
2019-04-10 |
Amunix Pharmaceuticals, Inc. |
Extended recombinant polypeptides and compositions comprising same
|
SI3260136T1
(sl)
|
2009-03-17 |
2021-05-31 |
Theraclone Sciences, Inc. |
Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
|
BRPI1012676A2
(pt)
|
2009-04-01 |
2016-04-05 |
Genentech Inc |
anticorpos anti-fcrh5 e imunoconjugados e métodos de uso
|
WO2010118243A2
(en)
|
2009-04-08 |
2010-10-14 |
Genentech, Inc. |
Use of il-27 antagonists to treat lupus
|
CA2759700A1
(en)
|
2009-04-23 |
2010-10-28 |
Danisco Us Inc. |
Three-dimensional structure of isoprene synthase and its use thereof for generating variants
|
SG175305A1
(en)
|
2009-04-23 |
2011-11-28 |
Theraclone Sciences Inc |
Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
|
FI121712B
(fi)
|
2009-04-30 |
2011-03-15 |
Ab Enzymes Oy |
Uusi sieniperäinen proteaasi ja sen käyttö
|
FI121711B
(fi)
|
2009-04-30 |
2011-03-15 |
Ab Enzymes Oy |
Sieniperäinen seriiniproteaasi ja sen käyttö
|
WO2010133644A2
(en)
|
2009-05-19 |
2010-11-25 |
Danisco A/S |
Amylase polypeptides
|
CA2762302A1
(en)
|
2009-05-20 |
2010-11-25 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
LT2440241T
(lt)
|
2009-06-08 |
2017-10-10 |
Amunix Operating Inc. |
Augimo hormonų polipeptidai ir jų gamybos bei panaudojimo būdai
|
JP5839597B2
(ja)
|
2009-06-08 |
2016-01-06 |
アムニクス オペレーティング インコーポレイテッド |
グルコース調節ポリペプチド並びにその作成及び使用方法
|
TW201412988A
(zh)
|
2009-06-17 |
2014-04-01 |
Danisco Us Inc |
使用dxp及mva途徑之改良之異戊二烯製造
|
TWI434921B
(zh)
|
2009-06-17 |
2014-04-21 |
Danisco Us Inc |
從生物異戊二烯組合物製造燃料成分之方法及系統
|
FI121851B
(fi)
|
2009-07-08 |
2011-05-13 |
Ab Enzymes Oy |
Sieniperäinen proteaasi ja sen käyttö
|
MX2012000705A
(es)
|
2009-07-15 |
2012-03-07 |
Abbott Lab |
Mejoramiento de produccion celular a traves de mecanotransduccion.
|
EP2454281B1
(en)
|
2009-07-17 |
2018-11-14 |
Omeros Corporation |
Masp isoforms as inhibitors of complement activation
|
WO2011011689A2
(en)
|
2009-07-23 |
2011-01-27 |
The Regents Of The University Of Michigan |
Method for enzymatic production of decarboxylated polyketides and fatty acids
|
AU2010278844A1
(en)
|
2009-07-31 |
2012-02-09 |
Genentech, Inc. |
Inhibition of tumor metastasis using Bv8- or G-CSF-antagonists
|
AR077942A1
(es)
|
2009-08-19 |
2011-10-05 |
Danisco |
Variantes de glucoamilasa
|
WO2011022465A1
(en)
|
2009-08-19 |
2011-02-24 |
Danisco Us Inc. |
Combinatorial variants of glucoamylase with improved specific activity and/or thermostability
|
EP2470670A4
(en)
|
2009-08-24 |
2013-07-10 |
Amunix Operating Inc |
COAGULATION FACTOR VII COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
|
JP5787891B2
(ja)
|
2009-09-01 |
2015-09-30 |
ジェネンテック, インコーポレイテッド |
改変されたプロテインa溶離による向上したタンパク質精製
|
US9321823B2
(en)
|
2009-09-02 |
2016-04-26 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
EP3187877A1
(en)
|
2009-09-25 |
2017-07-05 |
XOMA Technology Ltd. |
Screening methods
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
MX368790B
(es)
|
2009-10-15 |
2019-10-16 |
Genentech Inc |
Factores de crecimiento de fibroblasto quimericos con especificidad de receptor alterada.
|
CN102711828B
(zh)
|
2009-10-20 |
2015-06-17 |
Abbvie公司 |
使用蛋白a亲和色谱法分离和纯化抗-il-13抗体
|
CA2778442A1
(en)
|
2009-10-22 |
2011-04-28 |
Genentech, Inc. |
Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
|
KR20120102642A
(ko)
|
2009-10-22 |
2012-09-18 |
제넨테크, 인크. |
축삭 변성의 조절
|
WO2011056502A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Bone morphogenetic protein receptor type ii compositions and methods of use
|
WO2011056494A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
|
WO2011056497A1
(en)
|
2009-10-26 |
2011-05-12 |
Genentech, Inc. |
Activin receptor type iib compositions and methods of use
|
US20110098862A1
(en)
|
2009-10-27 |
2011-04-28 |
ExxonMobil Research Engineering Company Law Department |
Multi-stage processes and control thereof
|
US20110110942A1
(en)
|
2009-11-12 |
2011-05-12 |
Genentech, Inc. |
Method of promoting dendritic spine density
|
AU2010324686B2
(en)
|
2009-11-30 |
2016-05-19 |
Genentech, Inc. |
Antibodies for treating and diagnosing tumors expressing SLC34A2 (TAT211 = SEQID2 )
|
US9096843B2
(en)
|
2009-12-01 |
2015-08-04 |
Novo Nordisk A/S |
Peptidyl α-hydroxyglycine α-amidating lyases
|
WO2011080050A2
(en)
|
2009-12-11 |
2011-07-07 |
Novartis Ag |
Binding molecules
|
TWI505836B
(zh)
|
2009-12-11 |
2015-11-01 |
Genentech Inc |
抗-vegf-c抗體及其使用方法
|
DK2513135T3
(da)
|
2009-12-18 |
2020-05-18 |
Csl Ltd |
Fremgangsmåde til oprensning af polypeptider
|
WO2011087810A1
(en)
|
2009-12-21 |
2011-07-21 |
Ambrx, Inc. |
Modified porcine somatotropin polypeptides and their uses
|
SG2014011340A
(en)
|
2009-12-21 |
2014-07-30 |
Genentech Inc |
Antibody formulation
|
MX349301B
(es)
|
2009-12-21 |
2017-07-21 |
Ambrx Inc |
Polipéptidos de somatotropina bovina modificados y sus usos.
|
FI122937B
(fi)
|
2009-12-30 |
2012-09-14 |
Roal Oy |
Menetelmä selluloosamateriaalin käsittelemiseksi sekä tässä käyttökelpoiset CBH II/Cel6A entsyymit
|
PE20170687A1
(es)
|
2010-01-28 |
2017-06-13 |
Glaxo Group Ltd |
Proteinas de enlace a cd127
|
BR112012021261A2
(pt)
|
2010-02-23 |
2020-01-07 |
Sanofi |
Anticorpo de integrina anti-alfa2 humanizada, uso do mesmo, ácido nucleico isolado codificando um anticorpo de integrina anti-alfa2beta1, vetor, célula hospedeira, composição, kit e anticorpo
|
AU2011221226A1
(en)
|
2010-02-23 |
2012-08-16 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
UA108227C2
(xx)
|
2010-03-03 |
2015-04-10 |
|
Антигензв'язуючий білок
|
JP6148013B2
(ja)
|
2010-03-05 |
2017-06-14 |
リグショスピタレト |
補体活性化のキメラ抑制分子
|
EP2552945B1
(en)
|
2010-03-29 |
2018-05-02 |
DuPont Nutrition Biosciences ApS |
Polypeptides having transgalactosylating activity
|
MX2012011112A
(es)
|
2010-03-31 |
2012-10-15 |
Boehringer Ingelheim Int |
Anticuerpos anti-cd40.
|
WO2011133931A1
(en)
|
2010-04-22 |
2011-10-27 |
Genentech, Inc. |
Use of il-27 antagonists for treating inflammatory bowel disease
|
JP2013533732A
(ja)
|
2010-05-03 |
2013-08-29 |
ジェネンテック, インコーポレイテッド |
腫瘍の診断と治療のための組成物と方法
|
CN102985437B
(zh)
|
2010-05-28 |
2016-05-25 |
弗·哈夫曼-拉罗切有限公司 |
通过下调ldh和pdhk表达降低乳酸水平和增加多肽生产
|
EP2576622A4
(en)
|
2010-06-01 |
2013-11-27 |
Univ Monash |
ANTIBODIES AGAINST RECEPTOR TYROSINE KINASE C-MET
|
TW201210612A
(en)
|
2010-06-03 |
2012-03-16 |
Glaxo Group Ltd |
Humanised antigen binding proteins
|
US8933282B2
(en)
|
2010-06-17 |
2015-01-13 |
Danisco Us Inc. |
Fuel compositions comprising isoprene derivatives
|
KR101768118B1
(ko)
|
2010-06-25 |
2017-08-14 |
인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) |
기도 감염의 치료를 위한 방법 및 약학 조성물
|
BR112013001637A2
(pt)
|
2010-07-22 |
2016-05-24 |
Glaxosmithkline Biolog Sa |
proteína ligadora de antígeno, molécula de ácido nucleico, vetor de expressão, célula hospedeira recombinante, métodos para produção de proteína ligadora de antígeno, e para detectar mage-a3 e/ou mage-a6 em tecido de humano fixado com formalina e infiltrado em parafina.
|
CA2807558A1
(en)
|
2010-08-06 |
2012-02-09 |
Danisco Us Inc. |
Production of isoprene under neutral ph conditions
|
CN103068997A
(zh)
|
2010-08-06 |
2013-04-24 |
丹尼斯科美国公司 |
中性pH糖化和发酵
|
EP2420250A1
(en)
|
2010-08-13 |
2012-02-22 |
Universitätsklinikum Münster |
Anti-Syndecan-4 antibodies
|
JP2013540701A
(ja)
|
2010-08-12 |
2013-11-07 |
セラクローン サイエンシーズ, インコーポレイテッド |
抗赤血球凝集素抗体組成物およびその使用方法
|
BR112013003279A2
(pt)
|
2010-08-13 |
2016-06-14 |
Genentech In |
“métodos para tratar uma doença, método para neutralizar ou bloquear a atividade de il-1ß e/ou il-18, anticorpo, usos de um anticorpo e usos de um anticorpo monoclonal”
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
RS65223B1
(sr)
|
2010-08-17 |
2024-03-29 |
Ambrx Inc |
Modifikovani polipeptidi relaksina i njihova primena
|
EP2608682B1
(en)
|
2010-08-24 |
2017-12-13 |
Danisco US Inc. |
Method of making a snack bar comprising a low temperature rice protein concentrate
|
CN102380091A
(zh)
|
2010-08-31 |
2012-03-21 |
健能隆医药技术(上海)有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
WO2012030904A2
(en)
|
2010-08-31 |
2012-03-08 |
Theraclone Sciences, Inc. |
Human immunodeficiency virus (hiv)-neutralizing antibodies
|
AU2011302522A1
(en)
|
2010-09-15 |
2013-05-02 |
Aligna Technologies, Inc. |
Bioproduction of aromatic chemicals from lignin-derived compounds
|
MX2013003182A
(es)
|
2010-09-20 |
2013-04-24 |
Abbvie Inc |
Purificacion de anticuerpos por cromatografia de lecho movil simulada.
|
TWI480288B
(zh)
|
2010-09-23 |
2015-04-11 |
Lilly Co Eli |
牛顆粒細胞群落刺激因子及其變體之調配物
|
EP2625197B1
(en)
|
2010-10-05 |
2016-06-29 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
US9345764B2
(en)
|
2010-10-08 |
2016-05-24 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin modulators and uses thereof
|
US9347950B2
(en)
|
2010-10-08 |
2016-05-24 |
Shanghai Kexin Biotech Co., Ltd. |
Moesin fragments associated with immune thrombocytopenia
|
WO2012045281A1
(en)
|
2010-10-08 |
2012-04-12 |
Shanghai Kexin Biotech Co., Ltd. |
Diagnostic and therapeutic uses of moesin fragments
|
KR101641756B1
(ko)
|
2010-10-08 |
2016-07-21 |
상하이 켁신 바이오테크 씨오., 엘티디. |
모에신 단편 및 그의 용도
|
JP5868410B2
(ja)
|
2010-10-08 |
2016-02-24 |
シャンハイ クーシン バイオテック カンパニー,リミテッド |
再生不良性貧血と関連しているモエシン断片
|
WO2012058494A2
(en)
|
2010-10-27 |
2012-05-03 |
Danisco Us Inc. |
Isoprene synthase variants for improved production of isoprene
|
FI123942B
(fi)
|
2010-10-29 |
2013-12-31 |
Ab Enzymes Oy |
Sieniperäisen seriiniproteaasin variantteja
|
EA030436B1
(ru)
|
2010-11-04 |
2018-08-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
АНТИТЕЛА К IL-23p19 ИЛИ ИХ АНТИГЕНСВЯЗЫВАЮЩИЕ ФРАГМЕНТЫ, ИХ ПРИМЕНЕНИЕ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЭТИ АНТИТЕЛА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ВЫДЕЛЕННЫЕ ПОЛИНУКЛЕОТИДЫ, ЭКСПРЕССИОННЫЕ ВЕКТОРЫ И КЛЕТКИ ДЛЯ ПОЛУЧЕНИЯ АНТИТЕЛ
|
JP2013542736A
(ja)
|
2010-11-05 |
2013-11-28 |
アッヴィ・インコーポレイテッド |
細胞培養における合成培地開発のための効率的および効果的な栄養補助剤のスクリーニング
|
EP2640831A1
(en)
|
2010-11-17 |
2013-09-25 |
Sea Lane Biotechnologies,llc. |
Influenza virus neutralizing agents that mimic the binding site of an influenza neutralizing antibody
|
BR112013016264A2
(pt)
|
2010-12-22 |
2018-06-19 |
Danisco Us Inc |
produção biológica de açúcares de pentose com o uso de células recombinantes
|
BR112013018316A2
(pt)
|
2010-12-22 |
2018-09-11 |
Danisco Us Inc |
composições e métodos para produção aprimorada de isopreno usando dois tipos de enzimas ispg
|
KR101941514B1
(ko)
|
2010-12-22 |
2019-01-23 |
테바 파마슈티컬즈 오스트레일리아 피티와이 엘티디 |
개선된 반감기를 가지는 변형된 항체
|
KR20140012098A
(ko)
|
2011-02-14 |
2014-01-29 |
테라클론 사이언시스, 아이엔씨. |
인플루엔자의 치료 및 진단을 위한 조성물 및 방법
|
WO2012122528A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Bispecific three-chain antibody-like molecules
|
WO2012122512A1
(en)
|
2011-03-10 |
2012-09-13 |
Hco Antibody, Inc. |
Recombinant production of mixtures of single chain antibodies
|
BR112013023576A2
(pt)
|
2011-03-15 |
2016-12-06 |
Theraclone Sciences Inc |
composições e métodos para a terapia e diagnóstico de influenza
|
US20120238730A1
(en)
|
2011-03-15 |
2012-09-20 |
Abbott Laboratories |
Integrated approach to the isolation and purification of antibodies
|
WO2012128810A1
(en)
|
2011-03-23 |
2012-09-27 |
Abbott Laboratories |
Methods and systems for the analysis of protein samples
|
CN114642731A
(zh)
|
2011-03-31 |
2022-06-21 |
豪夫迈·罗氏有限公司 |
施用β7整联蛋白拮抗剂的方法
|
FI123425B
(fi)
|
2011-03-31 |
2013-04-30 |
Ab Enzymes Oy |
Proteaasientsyymi ja sen käytöt
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
WO2012149288A1
(en)
|
2011-04-29 |
2012-11-01 |
Danisco Us Inc. |
Single ph process for starch liquefaction and saccharification for high-density glucose syrups
|
CN107903325B
(zh)
|
2011-05-16 |
2021-10-29 |
埃泰美德(香港)有限公司 |
多特异性fab融合蛋白及其使用方法
|
MY192843A
(en)
|
2011-06-03 |
2022-09-12 |
Xoma Technology Ltd |
Antibodies specific for tgf-beta
|
JP2013040160A
(ja)
|
2011-07-01 |
2013-02-28 |
Genentech Inc |
自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
|
CN107915775B
(zh)
|
2011-07-11 |
2022-07-12 |
伊克诺斯科学公司 |
结合ox40的抗体及其用途
|
US8951764B2
(en)
|
2011-08-05 |
2015-02-10 |
Danisco Us Inc. |
Production of isoprenoids under neutral pH conditions
|
CN103890008A
(zh)
|
2011-08-17 |
2014-06-25 |
霍夫曼-拉罗奇有限公司 |
在顽固性肿瘤中抑制血管发生
|
US8822651B2
(en)
|
2011-08-30 |
2014-09-02 |
Theraclone Sciences, Inc. |
Human rhinovirus (HRV) antibodies
|
CN103945861B
(zh)
|
2011-09-12 |
2018-06-05 |
阿穆尼克斯运营公司 |
胰高血糖素样肽-2组合物及其制备和使用方法
|
EP2758438A1
(en)
|
2011-09-23 |
2014-07-30 |
Amgen Research (Munich) GmbH |
Bispecific binding molecules for 5t4 and cd3
|
US20130109055A1
(en)
|
2011-10-31 |
2013-05-02 |
Bp Corporation North America Inc. |
Use of mammalian promoters in filamentous fungi
|
CA2851855A1
(en)
|
2011-10-31 |
2013-05-10 |
Bp Corporation North America Inc. |
Use of plant promoters in filamentous fungi
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對bcma之e3以及cd3的結合分子
|
PL2780373T3
(pl)
|
2011-11-16 |
2020-03-31 |
Boehringer Ingelheim International Gmbh |
Przeciwciała anty il-36r
|
DK2785744T3
(da)
|
2011-12-01 |
2017-11-27 |
Innovent Biologics Inc |
Proteininhibitorer til komplement- og vegf-pathways og fremgangsmåder til anvendelse deraf
|
JP6415326B2
(ja)
|
2011-12-16 |
2018-10-31 |
ブラスケム エス.エー. |
改変された微生物およびそれを用いてブタジエンを作製する方法
|
WO2013091903A1
(en)
|
2011-12-22 |
2013-06-27 |
Novo Nordisk A/S |
Anti-crac channel antibodies
|
SG11201403437TA
(en)
|
2011-12-22 |
2014-07-30 |
Genentech Inc |
Ion exchange membrane chromatography
|
BR112014017141A2
(pt)
|
2012-01-19 |
2019-09-24 |
Univ Cincinnati |
método de tratamento de diabetes usando-se apolipoproteína a-iv não glicosilada
|
AR091305A1
(es)
|
2012-01-31 |
2015-01-28 |
Genentech Inc |
ANTICUERPOS ANTI-IgE Y SUS METODOS DE USO
|
BR112014018630A2
(pt)
|
2012-02-09 |
2017-07-04 |
Var2 Pharmaceuticals Aps |
alvejamento de glicanos de sulfato de condroitina
|
HUE046848T2
(hu)
|
2012-02-15 |
2020-03-30 |
Bioverativ Therapeutics Inc |
VIII. faktor készítmények és eljárások elõállításukra és alkalmazásukra
|
EP2822577B1
(en)
|
2012-02-15 |
2019-02-06 |
Bioverativ Therapeutics Inc. |
Recombinant factor viii proteins
|
US20150037334A1
(en)
|
2012-03-01 |
2015-02-05 |
Amgen Research (Munich) Gmbh |
Long life polypeptide binding molecules
|
WO2013158275A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Cell culture methods to reduce acidic species
|
WO2013158279A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Protein purification methods to reduce acidic species
|
US9181572B2
(en)
|
2012-04-20 |
2015-11-10 |
Abbvie, Inc. |
Methods to modulate lysine variant distribution
|
EP2841087B1
(en)
|
2012-04-27 |
2017-08-23 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Vascular endothelial growth factor antagonists and methods for their use
|
US9163263B2
(en)
|
2012-05-02 |
2015-10-20 |
The Goodyear Tire & Rubber Company |
Identification of isoprene synthase variants with improved properties for the production of isoprene
|
EP3326649B1
(en)
|
2012-05-03 |
2022-02-09 |
Boehringer Ingelheim International GmbH |
Anti-il-23p19 antibodies
|
US20140010820A1
(en)
|
2012-05-21 |
2014-01-09 |
Abbvie, Inc. |
Novel purification of non-human antibodies using protein a affinity chromatography
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
HRP20220545T1
(hr)
|
2012-06-08 |
2022-06-10 |
Dupont Nutrition Biosciences Aps |
Polipeptidi koji imaju transgalaktozilirajuću aktivnost
|
AU2013295721B2
(en)
|
2012-07-25 |
2017-07-20 |
University Of Cincinnati |
Method of treating type I diabetes using apolipoprotein AIV
|
US10232019B2
(en)
|
2012-07-25 |
2019-03-19 |
University Of Cincinnati |
Method of treating hyperglycemic disorders using apolipoprotein AIV
|
MX2015002099A
(es)
|
2012-08-22 |
2015-05-11 |
Dupont Nutrition Biosci Aps |
Variantes que tienen actividad glucoamilasa.
|
JOP20200308A1
(ar)
|
2012-09-07 |
2017-06-16 |
Novartis Ag |
جزيئات إرتباط il-18
|
EP2906693A1
(en)
|
2012-10-15 |
2015-08-19 |
Novo Nordisk Health Care AG |
Coagulation factor vii polypeptides
|
JP2016503818A
(ja)
|
2013-01-02 |
2016-02-08 |
グレンマーク ファーマシューティカルズ, エセ.アー. |
Tl1aと結合する抗体およびその使用
|
EP2948478B1
(en)
|
2013-01-25 |
2019-04-03 |
Amgen Inc. |
Antibodies targeting cdh19 for melanoma
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
RU2019120404A
(ru)
|
2013-03-13 |
2019-08-06 |
Дженентек, Инк. |
Составы антител
|
RU2707092C2
(ru)
|
2013-03-13 |
2019-11-22 |
Дженентек, Инк. |
Составы со сниженным окислением
|
US10653779B2
(en)
|
2013-03-13 |
2020-05-19 |
Genentech, Inc. |
Formulations with reduced oxidation
|
US20140314778A1
(en)
|
2013-03-13 |
2014-10-23 |
Genentech, Inc. |
Formulations with reduced oxidation
|
EP2968467B1
(en)
|
2013-03-13 |
2020-06-03 |
F.Hoffmann-La Roche Ag |
Formulations with reduced oxidation
|
WO2014142882A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Protein purification using displacement chromatography
|
AU2014240431A1
(en)
|
2013-03-14 |
2015-08-27 |
Abbvie Inc. |
Low acidic species compositions and methods for producing the same using displacement chromatography
|
EP2836515A1
(en)
|
2013-03-14 |
2015-02-18 |
AbbVie Inc. |
Low acidic species compositions and methods for producing and using the same
|
US20140271633A1
(en)
|
2013-03-14 |
2014-09-18 |
Abbvie Inc. |
Mammalian cell culture performance through surfactant supplementation of feed media
|
DK3611180T3
(da)
|
2013-03-15 |
2022-02-28 |
Biomolecular Holdings Llc |
Hybrid immunoglobulin indeholdende ikke-peptidyl-binding
|
PL2970449T3
(pl)
|
2013-03-15 |
2020-04-30 |
Amgen Research (Munich) Gmbh |
Jednołańcuchowe cząsteczki wiążące zawierające N-końcowy ABP
|
US9441035B2
(en)
|
2013-03-15 |
2016-09-13 |
Genentech, Inc. |
Cell culture media and methods of antibody production
|
US20140283157A1
(en)
|
2013-03-15 |
2014-09-18 |
Diadexus, Inc. |
Lipoprotein-associated phospholipase a2 antibody compositions and methods of use
|
AR095374A1
(es)
|
2013-03-15 |
2015-10-14 |
Amgen Res (Munich) Gmbh |
Moléculas de unión para bcma y cd3
|
EP3712252A1
(en)
|
2013-03-15 |
2020-09-23 |
F. Hoffmann-La Roche AG |
Cell culture compositions with antioxidants and methods for polypeptide production
|
WO2014145768A2
(en)
|
2013-03-15 |
2014-09-18 |
Bp Corporation North America Inc. |
Use of non-fungal 5' utrs in filamentous fungi
|
US9505849B2
(en)
|
2013-03-15 |
2016-11-29 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza M2 and CD3
|
EP2976362B1
(en)
|
2013-03-19 |
2019-10-23 |
Beijing Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
EP3933401A3
(en)
|
2013-03-27 |
2022-04-13 |
F. Hoffmann-La Roche AG |
Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
|
LT3004162T
(lt)
|
2013-05-31 |
2020-06-10 |
Genentech, Inc. |
Antikūnai prieš ląstelės sienelės teicho rūgštį ir konjugatai
|
US10548953B2
(en)
|
2013-08-14 |
2020-02-04 |
Bioverativ Therapeutics Inc. |
Factor VIII-XTEN fusions and uses thereof
|
AR097648A1
(es)
|
2013-09-13 |
2016-04-06 |
Amgen Inc |
Combinación de factores epigenéticos y compuestos biespecíficos que tienen como diana cd33 y cd3 en el tratamiento de leucemia mieloide
|
EP3626742A1
(en)
|
2013-09-27 |
2020-03-25 |
F. Hoffmann-La Roche AG |
Anti-pdl1 antibody formulations
|
WO2015069459A1
(en)
|
2013-11-05 |
2015-05-14 |
Novartis Ag |
Organic compounds
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
CA2932864A1
(en)
|
2013-12-11 |
2015-06-18 |
Dupont Nutrition Biosciences Aps |
A method for preparing a dairy product having a stable content of galacto-oligosaccharide(s)
|
CN105934253A
(zh)
|
2013-12-17 |
2016-09-07 |
豪夫迈·罗氏有限公司 |
使用pd-1轴结合拮抗剂和抗her2抗体治疗her2阳性癌症的方法
|
US20150210772A1
(en)
|
2013-12-17 |
2015-07-30 |
Genentech, Inc. |
Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody
|
AU2014364606A1
(en)
|
2013-12-17 |
2016-07-07 |
Genentech, Inc. |
Combination therapy comprising OX40 binding agonists and PD-1 axis binding antagonists
|
JP2017502672A
(ja)
|
2013-12-30 |
2017-01-26 |
メディシナル バイオコンバージェンス リサーチ センター |
抗krsモノクロナル抗体及びこれの用途
|
WO2015116902A1
(en)
|
2014-01-31 |
2015-08-06 |
Genentech, Inc. |
G-protein coupled receptors in hedgehog signaling
|
JP6511459B2
(ja)
|
2014-01-31 |
2019-05-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規な抗baff抗体
|
US20170044232A1
(en)
|
2014-02-04 |
2017-02-16 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
LT3116486T
(lt)
|
2014-03-14 |
2020-04-10 |
Biomolecular Holdings Llc |
Hibridinis imunoglobulinas, turintis nepetidilinę jungtį
|
CA2943357C
(en)
|
2014-03-25 |
2023-06-27 |
Genentech, Inc. |
Methods of preparing a poloxamer for use in cell culture medium
|
RU2016136716A
(ru)
|
2014-03-27 |
2018-04-28 |
Дженентек, Инк. |
Способы диагностики и лечения воспалительного заболевания кишечника
|
BR112016022345A2
(pt)
|
2014-03-31 |
2017-10-10 |
Genentech Inc |
terapia de combinação compreendendo agentes antiangiogênese e agonistas de ligação de ox40
|
US11345908B2
(en)
|
2014-05-30 |
2022-05-31 |
Braskem S.A. |
Modified microorganisms comprising an optimized system for oligosaccharide utilization and methods of using same
|
US20170183376A1
(en)
|
2014-06-24 |
2017-06-29 |
Insight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
US20170226552A1
(en)
|
2014-07-03 |
2017-08-10 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using cobalt
|
WO2016007764A1
(en)
|
2014-07-09 |
2016-01-14 |
Abbvie Inc. |
Methods for modulating the glycosylation profile of recombinant proteins using non-commonly used sugars
|
EP3708679A1
(en)
|
2014-07-24 |
2020-09-16 |
Boehringer Ingelheim International GmbH |
Biomarkers useful in the treatment of il-23a related diseases
|
AR101669A1
(es)
|
2014-07-31 |
2017-01-04 |
Amgen Res (Munich) Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
MX2017001403A
(es)
|
2014-07-31 |
2017-07-07 |
Amgen Res (Munich) Gmbh |
Constructo de anticuerpo de cadena individual biespecifico con distribucion mejorada de tejido.
|
JP6749312B2
(ja)
|
2014-07-31 |
2020-09-02 |
アムゲン リサーチ (ミュンヘン) ゲーエムベーハーAMGEN Research(Munich)GmbH |
最適化された種間特異的二重特異性単鎖抗体コンストラクト
|
MX2017003121A
(es)
|
2014-09-15 |
2017-08-02 |
Genentech Inc |
Formulaciones de anticuerpos.
|
WO2016059602A2
(en)
|
2014-10-16 |
2016-04-21 |
Glaxo Group Limited |
Methods of treating cancer and related compositions
|
CA2965502A1
(en)
|
2014-10-24 |
2016-04-28 |
Bristol-Myers Squibb Company |
Modified fgf-21 polypeptides and uses thereof
|
CA2966718A1
(en)
|
2014-11-07 |
2016-05-12 |
Dupont Nutrition Biosciences Aps |
Recombinant host cell expressing beta-galactosidase and/or transgalactosylating activity deficient in mannanase, cellulase and pectinase
|
CN106999583A
(zh)
|
2014-11-17 |
2017-08-01 |
豪夫迈·罗氏有限公司 |
包含ox40结合激动剂和pd‑1轴结合拮抗剂的组合疗法
|
JP6742314B2
(ja)
|
2014-12-03 |
2020-08-19 |
ジェネンテック, インコーポレイテッド |
抗黄色ブドウ球菌抗体リファマイシン複合体及びその使用
|
CA2975875A1
(en)
|
2015-02-04 |
2016-08-11 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
EP3253794A1
(en)
|
2015-02-04 |
2017-12-13 |
Boehringer Ingelheim International GmbH |
Methods of treating inflammatory diseases
|
WO2016130523A1
(en)
|
2015-02-09 |
2016-08-18 |
Danisco Us Inc |
Fungal strains and methods of use
|
EP3978530A1
(en)
|
2015-02-26 |
2022-04-06 |
F. Hoffmann-La Roche AG |
Integrin beta7 antagonists and methods of treating crohn's disease
|
WO2016141111A1
(en)
|
2015-03-03 |
2016-09-09 |
Xoma (Us) Llc |
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery
|
WO2016144773A1
(en)
|
2015-03-06 |
2016-09-15 |
Abbvie Inc. |
Arabinosylated glycoproteins
|
ES2820768T3
(es)
|
2015-04-03 |
2021-04-22 |
Xoma Technology Ltd |
Tratamiento del cáncer usando inhibidores de TGF-beta y PD-1
|
EP3283109A1
(en)
|
2015-04-14 |
2018-02-21 |
Boehringer Ingelheim International GmbH |
Methods of treating diseases
|
MX2017013348A
(es)
|
2015-04-17 |
2018-08-01 |
Amgen Res Munich Gmbh |
Construcciones de anticuerpos biespecificos contra cdh3 y cd3.
|
WO2016191169A1
(en)
|
2015-05-22 |
2016-12-01 |
Dupont Nutrition Biosciences Aps |
Acetolactate decarboxylase
|
KR20180013881A
(ko)
|
2015-05-29 |
2018-02-07 |
제넨테크, 인크. |
암에서의 pd-l1 프로모터 메틸화
|
JP6896650B2
(ja)
|
2015-06-17 |
2021-06-30 |
ジェネンテック, インコーポレイテッド |
Pd−1軸結合アンタゴニスト及びタキサンを使用した局所進行性または転移性乳癌の治療方法
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
TW202346349A
(zh)
|
2015-07-31 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
JP6909203B2
(ja)
|
2015-08-03 |
2021-07-28 |
バイオベラティブ セラピューティクス インコーポレイテッド |
第ix因子融合タンパク質及びそれらの製造方法及び使用方法
|
TW202330904A
(zh)
|
2015-08-04 |
2023-08-01 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
MX2018001644A
(es)
|
2015-08-11 |
2018-11-09 |
Wuxi Biologics Cayman Inc |
Anticuerpos anti-pd-1 novedosos.
|
MX2018002617A
(es)
|
2015-09-02 |
2018-07-06 |
Dupont Nutrition Biosci Aps |
Glucosido hidrolasas y su uso en la prevencion y/o tratamiento de infeccion patogena en un animal.
|
EP3347376B1
(en)
|
2015-09-07 |
2021-01-06 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel igfr-like receptor and uses thereof
|
TWI811716B
(zh)
|
2015-09-18 |
2023-08-11 |
德商百靈佳殷格翰國際股份有限公司 |
治療發炎性疾病之方法
|
CN108472379B
(zh)
|
2015-12-30 |
2022-06-21 |
豪夫迈·罗氏有限公司 |
减少聚山梨酯降解的制剂
|
AU2016381694A1
(en)
|
2015-12-30 |
2018-07-05 |
Genentech, Inc. |
Use of tryptophan derivatives for protein formulations
|
DK3411404T3
(da)
|
2016-02-03 |
2023-01-30 |
Amgen Res Munich Gmbh |
Psma- og cd3-bispecifikke t-celleinddragende antistofkonstruktioner
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
EP3411402B1
(en)
|
2016-02-03 |
2021-12-22 |
Amgen Research (Munich) GmbH |
Bcma and cd3 bispecific t cell engaging antibody constructs
|
CA3019952A1
(en)
|
2016-02-04 |
2017-08-10 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
US11767362B1
(en)
|
2016-03-15 |
2023-09-26 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of treating cancers using PD-1 axis binding antagonists and anti-GPC3 antibodies
|
US10870701B2
(en)
|
2016-03-15 |
2020-12-22 |
Generon (Shanghai) Corporation Ltd. |
Multispecific fab fusion proteins and use thereof
|
US10822416B2
(en)
|
2016-03-23 |
2020-11-03 |
Mabspace Biosciences (Suzhou) Co., Ltd |
Anti-PD-L1 antibodies
|
CN109328069B
(zh)
|
2016-04-15 |
2023-09-01 |
亿一生物医药开发(上海)有限公司 |
Il-22在治疗坏死性小肠结肠炎中的用途
|
EP3744733A3
(en)
|
2016-04-15 |
2021-02-24 |
Boehringer Ingelheim International GmbH |
Methods of treating inflammatory diseases
|
EP3464354B1
(en)
|
2016-06-02 |
2021-07-28 |
Bloom Diagnostics AG |
Antibodies that bind to human anti-müllerian hormone (amh) and their uses
|
DK3478831T3
(da)
|
2016-06-30 |
2021-04-19 |
Danisco Us Inc |
Asparaginproteaser
|
WO2018026748A1
(en)
|
2016-08-01 |
2018-02-08 |
Xoma (Us) Llc |
Parathyroid hormone receptor 1 (pth1r) antibodies and uses thereof
|
WO2018029124A1
(en)
|
2016-08-08 |
2018-02-15 |
F. Hoffmann-La Roche Ag |
Therapeutic and diagnostic methods for cancer
|
MX2019002934A
(es)
|
2016-09-16 |
2019-06-17 |
Dupont Nutrition Biosci Aps |
Variantes de acetolactato descarboxilasa que tienen actividad especifica mejorada.
|
KR20190049866A
(ko)
|
2016-09-20 |
2019-05-09 |
우시 바이올로직스 아일랜드 리미티드 |
신규한 항-pcsk9 항체
|
RU2763378C2
(ru)
|
2016-09-23 |
2021-12-28 |
ДюПон НЬЮТРИШН БАЙОСАЙЕНСИЗ АпС |
ПРИМЕНЕНИЕ АКТИВНЫХ ПРИ НИЗКОМ ЗНАЧЕНИИ pH АЛЬФА-1,4/1,6-ГЛИКОЗИДГИДРОЛАЗ В КАЧЕСТВЕ КОРМОВОЙ ДОБАВКИ ДЛЯ ЖВАЧНЫХ ЖИВОТНЫХ ДЛЯ УЛУЧШЕНИЯ ПЕРЕВАРИВАНИЯ КРАХМАЛА
|
CA3038679A1
(en)
|
2016-09-28 |
2018-04-05 |
Xoma (Us) Llc |
Antibodies that bind interleukin-2 and uses thereof
|
KR102593668B1
(ko)
|
2016-10-04 |
2023-10-24 |
다니스코 유에스 인크. |
유도 기질 부재 하의 사상 진균 세포에서의 단백질 생산
|
EP3677597A1
(en)
|
2016-10-14 |
2020-07-08 |
Boehringer Ingelheim International GmbH |
Methods of treating diseases
|
EP3526248A4
(en)
|
2016-10-17 |
2020-07-08 |
Musc Foundation for Research Development |
COMPOSITIONS AND METHODS FOR TREATING LESIONS OF THE CENTRAL VENEER SYSTEM
|
WO2018093752A1
(en)
|
2016-11-15 |
2018-05-24 |
Danisco Us Inc. |
Filamentous fungi with improved protein production
|
WO2018138376A1
(en)
|
2017-01-30 |
2018-08-02 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Novel igfr-like 2 receptor and uses thereof
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
TW201837051A
(zh)
|
2017-02-08 |
2018-10-16 |
美商必治妥美雅史谷比公司 |
包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途
|
WO2018152496A1
(en)
|
2017-02-17 |
2018-08-23 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Compositions and methods for the diagnosis and treatment of zika virus infection
|
WO2018164876A1
(en)
|
2017-03-06 |
2018-09-13 |
Dupont Nutrition Biosciences Aps |
Novel fungal fucosidases and their use in preventing and/or treating a pathogenic infection in an animal
|
EP4095161A1
(en)
|
2017-03-15 |
2022-11-30 |
Tsinghua University |
Novel anti-trkb antibodies
|
WO2018182284A1
(ko)
|
2017-03-27 |
2018-10-04 |
재단법인 의약바이오컨버젼스연구단 |
세포 외막에 노출되는 라이실-tRNA 합성효소 N-말단 영역에 특이적으로 결합하는 항체
|
US20180273627A1
(en)
|
2017-03-27 |
2018-09-27 |
Boehringer Ingelheim International Gmbh |
Anti il-36r antibodies combination therapy
|
EP3615569A1
(en)
|
2017-04-25 |
2020-03-04 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of epstein barr virus infection
|
UY37726A
(es)
|
2017-05-05 |
2018-11-30 |
Amgen Inc |
Composición farmacéutica que comprende constructos de anticuerpos biespecíficos para almacenamiento y administración mejorados
|
US10793634B2
(en)
|
2017-06-09 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Anti-TrkB antibodies
|
US11827669B2
(en)
|
2017-07-19 |
2023-11-28 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
|
US11339221B2
(en)
|
2017-11-01 |
2022-05-24 |
Tufts Medical Center, Inc. |
Bispecific antibody constructs and methods of use
|
MX2020006007A
(es)
|
2017-12-11 |
2020-08-17 |
Amgen Inc |
Procedimiento de fabricacion continuo para productos de anticuerpos biespecificos.
|
TW201940518A
(zh)
|
2017-12-29 |
2019-10-16 |
美商安進公司 |
針對muc17和cd3之雙特異性抗體構建體
|
EA202091974A1
(ru)
|
2018-02-21 |
2020-12-08 |
Селджин Корпорейшн |
Связывающие bcma антитела и их применение
|
KR102340989B1
(ko)
|
2018-03-28 |
2021-12-20 |
에이비온 주식회사 |
클라우딘 3의 ecl-2에 특이적으로 결합하는 항체, 이의 단편 및 이들의 용도
|
EP3774916A2
(en)
|
2018-04-06 |
2021-02-17 |
Biolegend, Inc. |
Anti-tetraspanin 33 agents and compositions and methods for making and using the same
|
EP3788071A1
(en)
|
2018-05-02 |
2021-03-10 |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services |
Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
|
MA52968A
(fr)
|
2018-06-23 |
2021-04-28 |
Hoffmann La Roche |
Méthodes de traitement du cancer du poumon à l'aide d'un antagoniste de liaison à l'axe pd-1, d'un agent de platine et d'un inhibiteur de la topoisomérase ii
|
KR20210027436A
(ko)
|
2018-06-29 |
2021-03-10 |
베링거 인겔하임 인터내셔날 게엠베하 |
자가면역 질환을 치료하는데 사용하기 위한 항-cd40 항체
|
CN112789504A
(zh)
|
2018-07-13 |
2021-05-11 |
瓦克特诊断有限责任公司 |
使用重组疟疾蛋白var2csa分离胎儿来源的循环细胞
|
KR20210042936A
(ko)
|
2018-08-08 |
2021-04-20 |
제넨테크, 인크. |
단백질 제제를 위한 트립토판 유도체 및 l-메티오닌의 용도
|
EP3857230B1
(en)
|
2018-09-21 |
2023-06-07 |
F. Hoffmann-La Roche AG |
Diagnostic methods for triple-negative breast cancer
|
WO2020068557A1
(en)
|
2018-09-25 |
2020-04-02 |
BioLegend, Inc. |
Anti-tlr9 agents and compositions and methods for making and using the same
|
BR112021005669A2
(pt)
|
2018-09-28 |
2021-06-22 |
Amgen Inc. |
anticorpos contra bcma solúvel
|
MX2021003976A
(es)
|
2018-10-11 |
2021-05-27 |
Amgen Inc |
Procesamiento posterior de constructos de anticuerpos biespecificos.
|
CN113366021A
(zh)
|
2018-10-23 |
2021-09-07 |
格雷卡迪亚尔诊断有限公司 |
糖基化Apo J特异性抗体及其用途
|
KR20220004979A
(ko)
|
2019-03-27 |
2022-01-12 |
유엠씨 우트레크트 홀딩 비.브이. |
조작된 iga 항체 및 사용 방법
|
AU2020267874A1
(en)
|
2019-05-09 |
2021-10-28 |
Boehringer Ingelheim International Gmbh |
Anti-Sema3A antibodies and their uses for treating eye or ocular diseases
|
WO2020238730A1
(zh)
|
2019-05-24 |
2020-12-03 |
三优生物医药(上海)有限公司 |
新型cldn18.2结合分子
|
JP2022537650A
(ja)
|
2019-06-13 |
2022-08-29 |
アムジエン・インコーポレーテツド |
生物製剤の製造における自動化された生物量に基づく灌流制御
|
TW202115112A
(zh)
|
2019-06-27 |
2021-04-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗-angpt2抗體
|
KR102478445B1
(ko)
|
2019-07-18 |
2022-12-20 |
주식회사 큐어바이오테라퓨틱스 |
Wrs 단백질에 특이적으로 결합하는 항체 및 이의 용도
|
AU2020338947A1
(en)
|
2019-08-27 |
2022-03-31 |
Tonix Pharma Limited |
Modified TFF2 polypeptides
|
WO2021050640A1
(en)
|
2019-09-10 |
2021-03-18 |
Amgen Inc. |
Purification method for bispecific antigen-binding polypeptides with enhanced protein l capture dynamic binding capacity
|
KR102442204B1
(ko)
|
2019-09-20 |
2022-09-08 |
경북대학교 산학협력단 |
Cox2 단백질의 아세틸화 검출용 항체 및 이의 용도
|
TW202126685A
(zh)
|
2019-09-24 |
2021-07-16 |
德商百靈佳殷格翰國際股份有限公司 |
抗nrp1a抗體及其用於治療眼或眼部疾病之用途
|
EP4058485A1
(en)
|
2019-11-13 |
2022-09-21 |
Amgen Inc. |
Method for reduced aggregate formation in downstream processing of bispecific antigen-binding molecules
|
KR20220116504A
(ko)
|
2019-12-19 |
2022-08-23 |
바스프 에스이 |
정밀 화학물의 제조에서 공시 수율, 탄소-전환-효율 및 탄소 기질 적응성의 증가
|
MX2022007714A
(es)
|
2019-12-20 |
2022-07-19 |
Basf Se |
Disminucion de la toxicidad de terpenos y aumento de la posible produccion en microorganismos.
|
WO2021150824A1
(en)
|
2020-01-22 |
2021-07-29 |
Amgen Research (Munich) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
CN113461817A
(zh)
|
2020-03-31 |
2021-10-01 |
苏州泽璟生物制药股份有限公司 |
一种抗人cd47抗体及其抗原结合片段、制备方法和应用
|
JP2023522037A
(ja)
|
2020-04-15 |
2023-05-26 |
ジェネンテック, インコーポレイテッド |
銅損の軽減
|
BR112022023989A2
(pt)
|
2020-05-26 |
2023-02-07 |
Boehringer Ingelheim Int |
Anticorpos anti-pd-1
|
PE20231078A1
(es)
|
2020-06-02 |
2023-07-17 |
Arcus Biosciences Inc |
Anticuerpos anti-tigit
|
EP4165076A1
(en)
|
2020-06-15 |
2023-04-19 |
Sarepta Therapeutics, Inc. |
Adeno-associated virus antibodies and fragments thereof
|
CA3181820A1
(en)
|
2020-06-16 |
2021-12-23 |
Genentech, Inc. |
Methods and compositions for treating triple-negative breast cancer
|
EP3939999A1
(en)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Interleukin 11 receptor alpha subunit (il11ra) neutralizing antibodies and uses thereof
|
WO2022093641A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2a agents and compositions and methods for making and using the same
|
WO2022093640A1
(en)
|
2020-10-30 |
2022-05-05 |
BioLegend, Inc. |
Anti-nkg2c agents and compositions and methods for making and using the same
|
EP4240770A1
(en)
|
2020-11-06 |
2023-09-13 |
Amgen Research (Munich) GmbH |
Polypeptide constructs selectively binding to cldn6 and cd3
|
EP4240767A1
(en)
|
2020-11-06 |
2023-09-13 |
Amgen Inc. |
Polypeptide constructs binding to cd3
|
KR20230098335A
(ko)
|
2020-11-06 |
2023-07-03 |
암젠 인크 |
클리핑 비율이 감소된 항원 결합 도메인
|
CN112480248B
(zh)
|
2020-11-24 |
2023-05-05 |
三优生物医药(上海)有限公司 |
与cld18a2特异性结合的分子
|
CA3202339A1
(en)
|
2020-12-18 |
2022-06-23 |
Mei Jang |
Protein compositions and methods for producing and using the same
|
EP4314078A1
(en)
|
2021-04-02 |
2024-02-07 |
Amgen Inc. |
Mageb2 binding constructs
|
CA3226102A1
(en)
|
2021-07-23 |
2023-01-26 |
Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) |
Igfr-l1 antibodies and uses thereof
|
WO2023105087A1
(en)
|
2021-12-10 |
2023-06-15 |
Tubulis Gmbh |
Novel flt3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitors
|
EP4238988A1
(en)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Antibodies against sars-cov-2 and uses thereof
|
WO2023173011A1
(en)
|
2022-03-09 |
2023-09-14 |
Bristol-Myers Squibb Company |
Transient expression of therapeutic proteins
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|